[Federal Register Volume 70, Number 123 (Tuesday, June 28, 2005)]
[Rules and Regulations]
[Pages 37009-37010]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-12733]



========================================================================
Rules and Regulations
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains regulatory documents 
having general applicability and legal effect, most of which are keyed 
to and codified in the Code of Federal Regulations, which is published 
under 50 titles pursuant to 44 U.S.C. 1510.

The Code of Federal Regulations is sold by the Superintendent of Documents. 
Prices of new books are listed in the first FEDERAL REGISTER issue of each 
week.

========================================================================


Federal Register / Vol. 70, No. 123 / Tuesday, June 28, 2005 / Rules 
and Regulations

[[Page 37009]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

5 CFR Part 5502

RIN 3209-AA15


Supplemental Financial Disclosure Requirements for Employees of 
the Department of Health and Human Services

AGENCY: Department of Health and Human Services (HHS).

ACTION: Interim final rule.

-----------------------------------------------------------------------

SUMMARY: This interim final rule extends the due date for NIH employees 
to file a report of prohibited financial interests held on or acquired 
after February 3, 2005. The reports are now due no earlier than October 
3, 2005.

DATES: This interim final rule is effective June 28, 2005.

FOR FURTHER INFORMATION CONTACT: Edgar M. Swindell, Associate General 
Counsel, Office of the General Counsel, Ethics Division, Department of 
Health and Human Services, telephone (202) 690-7258, fax (202) 205-
9752.

SUPPLEMENTARY INFORMATION: The Executive Branch Financial Disclosure 
Regulation, 5 CFR part 2634, prescribes rules governing the public and 
confidential financial disclosure systems established under the Ethics 
in Government Act. With the approval of the Office of Government 
Ethics, an agency may supplement those regulations pursuant to 5 CFR 
2634.103. In an interim final rule published at 70 FR 5543 on February 
3, 2005, HHS added a new part 5502 to title 5. Among other provisions, 
NIH employees on duty as of the effective date of the interim final 
rule were required by Sec.  5502.106(c)(3) to report in writing within 
60 days after the effective date any financial interest prohibited by 5 
CFR 5501.110 that was held on the effective date.
    The specified report was due initially on April 4, 2005. The 
Designated Agency Ethics Official extended the deadline to July 5, 
2005, the maximum 90 day period provided under Sec.  5502.105. In 
response to comments submitted following the publication of the interim 
final rule, the Department is considering issuing revisions to the HHS 
supplemental ethics regulations, including part 5502. To allow time for 
any revisions to be fairly considered, the current reporting date must 
be deferred. Accordingly, Sec.  5502.106(c)(3) is amended to specify a 
new due date, October 3, 2005.
    For those new entrant or reassigned employees who enter on duty at 
the NIH after February 3, 2005, and before September 4, 2005, or for 
incumbent employees who acquire a prohibited financial interest during 
this period, the due date for the report is also changed to October 3, 
2005.
    Pursuant to 5 CFR 5501.110(g), the due date for the report 
determines the divestiture period specified in 5 CFR 2635.403(d), as 
applied to financial interests prohibited under 5 CFR 5501.110(c) and 
(d). As a consequence, the new deadline for any required divestitures 
will be January 2, 2006.
    Section 5502.105 is amended to allow the Designated Agency Ethics 
Official, for good cause, to extend reporting deadlines for reports 
required under part 5502 during the initial implementation phase for 
any reporting requirement, without regard to the 90 day maximum 
specified in the interim final rule.

Administrative Procedure Act

    Because this interim final rule involves only a procedural matter 
and extends a financial disclosure reporting deadline applicable to 
agency personnel, it is exempt under 5 U.S.C. 553(a)(2) and 553(b) from 
the requirement for notice and comment rulemaking. The deferral of the 
reporting requirement relieves restrictions under current law and thus 
is effective upon publication pursuant to 5 U.S.C. 553(d)(1).

Regulatory Flexibility Act

    This interim final rule will not have a significant economic impact 
on a substantial number of small entities because the rule amends a 
personnel provision affecting only HHS employees.

Paperwork Reduction Act

    This interim final rule does not prescribe information collection 
requirements that are subject to approval by the Office of Management 
and Budget.

Congressional Review Act

    As a provision related to agency personnel, this rulemaking is not 
a rule as defined in 5 U.S.C. 804, and does not require review by 
Congress.

Executive Orders 12866 and 12988

    Because this rule relates to HHS personnel, it is exempt from the 
provisions of Executive Orders 12866 and 12988.

List of Subjects 5 CFR Part 5502

    Conflict of interests, Ethics, Government employees, Reporting and 
recordkeeping requirements.

    Dated: June 10, 2005.
Edgar M. Swindell,
Designated Agency Ethics Official, Department of Health and Human 
Services.

    Dated: June 22, 2005.
Michael O. Leavitt,
Secretary, Department of Health and Human Services.
    Approved: June 22, 2005.
Marilyn L. Glynn,
Acting Director, Office of Government Ethics.

0
For the reasons discussed in the preamble, the Department of Health and 
Human Services, with the concurrence of the Office of Government 
Ethics, amends 5 CFR part 5502 as follows:

Title 5--[Amended]

Chapter XLV-Department of Health and Human Services

PART 5502--SUPPLEMENTAL FINANCIAL DISCLOSURE REQUIREMENTS FOR 
EMPLOYEES OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES

0
1. The authority citation for part 5502 continues to read as follows:

    Authority: 5 U.S.C. 301, 7301; 5 U.S.C. App. (Ethics in 
Government Act of 1978); E.O. 12674, 54 FR 15159, 3 CFR, 1989 Comp., 
p. 215, as modified by E.O. 12731, 55 FR 42547, 3 CFR, 1990 Comp., 
p. 306; 5 CFR 2634.103.

0
2. Revise Sec.  5502.105 to read as follows:

[[Page 37010]]

Sec.  5502.105  Agency procedures.

    (a) The designated agency ethics official or, with the concurrence 
of the designated agency ethics official, each of the separate agency 
components of HHS listed in Sec.  5501.102(a) of this chapter may 
prescribe procedures for the submission and review of each report filed 
under this part. These procedures may provide for filing extensions, 
for good cause shown, totaling not more than 90 days.
    (b) For good cause, the designated agency ethics official may 
extend the reporting deadlines for reports required under this part 
during the initial implementation phase for any reporting requirement, 
without regard to the 90 day maximum specified in paragraph (a) of this 
section.

0
3. Amend Sec.  5502.106 by revising paragraph (c) to read as follows:


Sec.  5502.106  Supplemental disclosure of prohibited financial 
interests applicable to employees of the Food and Drug Administration 
and the National Institutes of Health.

* * * * *
    (c) Report of prohibited financial interests.--(1) New entrant 
employees. A new FDA employee, other than a public filer or a 
confidential filer, shall report in writing within 30 days after 
entering on duty with the FDA any prohibited financial interest held 
upon commencement of employment with the agency. A new NIH employee, 
other than a public filer or a confidential filer, who enters on duty 
at the NIH after February 3, 2005, and before September 4, 2005, shall 
report in writing on or before October 3, 2005, any prohibited 
financial interest held upon commencement of employment with the 
agency. A new NIH employee, other than a public filer or a confidential 
filer, who enters on duty at the NIH on or after September 4, 2005, 
shall report in writing within 30 days after entering on duty with the 
NIH any prohibited financial interest held upon commencement of 
employment with the agency.
    (2) Reassigned employees. An employee of a separate agency 
component other than the FDA or of the remainder of HHS who is 
reassigned to a position at the FDA shall report in writing within 30 
days of entering on duty with the FDA any prohibited financial interest 
held on the effective date of the reassignment to the agency. An 
employee of a separate agency component other than the NIH or of the 
remainder of HHS who is reassigned to a position at the NIH after 
February 3, 2005, and before September 4, 2005, shall report in writing 
on or before October 3, 2005, any prohibited financial interest held on 
the effective date of the reassignment to the agency. An employee of a 
separate agency component other than the NIH or of the remainder of HHS 
who is reassigned to a position at the NIH on or after September 4, 
2005, shall report in writing within 30 days of entering on duty with 
the NIH any prohibited financial interest held on the effective date of 
the reassignment to the agency.
    (3) Incumbent employees. An incumbent employee of the FDA who 
acquires any prohibited financial interest shall report such interest 
in writing within 30 days after acquiring the financial interest. An 
incumbent employee of the NIH who acquires any prohibited financial 
interest after February 3, 2005, and before September 4, 2005, shall 
report such interest in writing on or before October 3, 2005. An 
incumbent employee of the NIH who acquires any prohibited financial 
interest on or after September 4, 2005, shall report such interest in 
writing within 30 days after acquiring the financial interest. An 
incumbent employee on duty at the NIH on February 3, 2005, shall report 
in writing on or before October 3, 2005, any prohibited financial 
interest held on February 3, 2005.

[FR Doc. 05-12733 Filed 6-23-05; 5 pm]
BILLING CODE 4150-03-P